- 71839-83-3Chromate(1-), bis(3-(4-((5-chloro-2-hydroxy-3-nitrophenyl)azo)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)-N-(2-hydroxyethyl)benzenesulfonamidato(2-))-, hydrogen, compd. with N-cyclohexylcyclohexanamine (1:1)
- 7184-60-3Cyclopentanecarboxylicacid,2-[(2S,4E,6Z,8R,9S,11R,13S,15S,16S)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl]-,(1R,2R)-
- 71846-67-87-Methoxy-6-methyl-1-indanone
- 71849-94-0Benzenesulfonic acid, 2,2'-[(1,2-dioxo-1,2-ethanediyl)diimino]bis[5-amino- (9CI)
- 71849-96-21H-Pyrazole-3-carboxylicacid, 4,5-dihydro-5-oxo-1-[(4-sulfophenyl)methyl]-
- 71850-70-9Ethanaminium, 2-amino-N-(2-(((2Z)-3-carboxy-1-oxo-2-propenyl)oxy)ethyl)-N,N-dimethyl-2-oxo-, dodecyl sulfate, polymer with 2-ethylhexyl 2-propenoate, ethyl 2-propenoate, methyl 2-propenoate, and 2-propenoic acid
- 71850-74-3Pentanoic acid,3-[2,2-dimethyl-1-oxo-3-[(1-oxopentyl)oxy]propoxy]-2,2-dimethylpropyl ester
- 71850-76-5Propanoic acid,3-[(chlorocarbonyl)thio]-, methyl ester
- 71856-54-75-amino-1-(2-bromophenyl)-1H-pyrazole-4-carbonitrile
- 718595-27-8L-Alanine,3-[[[2-[4,4'-bipiperidin]-1-yl-4-(1-methylethyl)-5-thiazolyl]carbonyl]amino]-N-(phenylsulfonyl)-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
1H-Indeno(2,1-c)pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide |
EINECS | 276-060-9 |
| CAS No. | 71839-14-0 | Density | N/A |
| PSA | 3.24000 | LogP | 4.72690 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C19H17N.BrH | Boiling Point | 434.2 °C at 760 mmHg |
| Molecular Weight | 340.263 | Flash Point | 191.6 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
1H-Indeno[2,1-c]pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide (9CI);2-Methyl-9-phenyl-2,3-dihydro-1H-indeno[2,1-c]pyridine hydrobromide (1:1);2,3-Dihydro-2-methyl-9-phenyl-1H-indeno(2,1-c)pyridine hydrobromide;2-Methyl-9-phenyl-2,3-dihydro-1-pyridindene hydrobromide; |
1H-Indeno(2,1-c)pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide Specification
The CAS registry number of 1H-Indeno(2,1-c)pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide is 71839-14-0. The IUPAC name is 2-methyl-9-phenyl-1,3-dihydroindeno[2,1-c]pyridine hydrobromide. Its EINECS registry number is 276-060-9. In addition, the molecular formula is C19H18BrN and the molecular weight is 340.26. It should be stored in a cool and dry place.
Physical properties about 1H-Indeno(2,1-c)pyridine,2,3-dihydro-2-methyl-9-phenyl-,hydrobromide are: (1)ACD/LogP: 4.06; (2)# of Rule of 5 Violations: 0; (3)#H bond acceptors: 1; (4)#H bond donors: 0; (5)#Freely Rotating Bonds: 1; (6)Polar Surface Area: 3.24 Å2; (7)Flash Point: 191.6 °C; (8)Enthalpy of Vaporization: 69.03 kJ/mol; (9)Boiling Point: 434.2 °C at 760 mmHg; (10)Vapour Pressure: 9.62E-08 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: Br.C\2=C1/c4c(\C(=C1CN(C/2)C)c3ccccc3)cccc4
(2)InChI: InChI=1/C19H17N.BrH/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14;/h2-11H,12-13H2,1H3;1H
(3)InChIKey: RFIIQJSREXZMBF-UHFFFAOYAD
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 150mg/kg (150mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Journal of Pharmacology and Experimental Therapeutics. Vol. 92, Pg. 249, 1948. |
| mouse | LD50 | intravenous | 40mg/kg (40mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Journal of Pharmacology and Experimental Therapeutics. Vol. 92, Pg. 249, 1948. |
| mouse | LD50 | oral | 275mg/kg (275mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Journal of Pharmacology and Experimental Therapeutics. Vol. 92, Pg. 249, 1948. |
| mouse | LD50 | subcutaneous | 260mg/kg (260mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Journal of Pharmacology and Experimental Therapeutics. Vol. 92, Pg. 249, 1948. |
What can I do for you?
Get Best Price
